The sirens' songs of confirmatory sepsis trials: Selection bias and sampling error

被引:111
作者
Natanson, C [1 ]
Esposito, CJ [1 ]
Banks, SM [1 ]
机构
[1] NIH, Warren G Magnuson Clin Ctr, Dept Crit Care Med, Bethesda, MD 20892 USA
关键词
sepsis; clinical trials; anti-inflammatory agents; infection; Gram-negative;
D O I
10.1097/00003246-199812000-00001
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1927 / 1931
页数:5
相关论文
共 23 条
[1]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[2]  
Abraham E, 1998, LANCET, V351, P929
[3]   p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial [J].
Abraham, E ;
Glauser, MP ;
Butler, T ;
Garbino, J ;
Gelmont, D ;
Laterre, PF ;
Kudsk, K ;
Bruining, HA ;
Otto, C ;
Tobin, E ;
Zwingelstein, C ;
Lesslauer, W ;
Leighton, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19) :1531-1538
[4]  
ABRAHAM E, 1998, INT C CHIC AM THOR S
[5]   The effects of ibuprofen on the physiology and survival of patients with sepsis [J].
Bernard, GR ;
Wheeler, AP ;
Russell, JA ;
Schein, R ;
Summer, WR ;
Steinberg, KP ;
Fulkerson, WJ ;
Wright, PE ;
Christman, BW ;
Dupont, WD ;
Higgins, SB ;
Swindell, BB .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :912-918
[6]   PROSTACYCLIN AND THROMBOXANE-A2 FORMATION IS INCREASED IN HUMAN SEPSIS SYNDROME - EFFECTS OF CYCLOOXYGENASE INHIBITION [J].
BERNARD, GR ;
REINES, HD ;
HALUSHKA, PV ;
HIGGINS, SB ;
METZ, CA ;
SWINDELL, BB ;
WRIGHT, PE ;
WATTS, FL ;
VRBANAC, JJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1095-1101
[7]   INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis [J].
Cohen, J ;
Carlet, J .
CRITICAL CARE MEDICINE, 1996, 24 (09) :1431-1440
[8]   CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK [J].
DHAINAUT, JFA ;
VINCENT, JL ;
RICHARD, C ;
LEJEUNE, P ;
MARTIN, C ;
FIEROBE, L ;
STEPHENS, S ;
NEY, UM ;
SOPWITH, M ;
MERCAT, A ;
EDOUARD, A ;
FRIEDMAN, G ;
MARIN, N ;
SCHLEMMER, B ;
LEPAPE, A ;
NOVAK, C .
CRITICAL CARE MEDICINE, 1995, 23 (09) :1461-1469
[9]   PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER CLINICAL-TRIAL [J].
DHAINAUT, JFA ;
TENAILLON, A ;
LETULZO, Y ;
SCHLEMMER, B ;
SOLET, JP ;
WOLFF, M ;
HOLZAPFEL, L ;
ZENI, F ;
DREYFUSS, D ;
MIRA, JP ;
DEVATHAIRE, F ;
GUINOT, P .
CRITICAL CARE MEDICINE, 1994, 22 (11) :1720-1728
[10]   Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial [J].
Dhainaut, JFA ;
Tenaillon, A ;
Hemmer, M ;
Damas, P ;
Le Tulzo, Y ;
Radermacher, P ;
Schaller, MD ;
Sollet, JP ;
Wolff, M ;
Holzapfel, L ;
Zeni, F ;
Vedrinne, JM ;
de Vathaire, F ;
Gourlay, ML ;
Guinot, P ;
Mira, JP ;
Holzapfel, L ;
Demingeon, G ;
Piralla, B ;
Zeni, F ;
Bertrand, JC ;
Motin, J ;
Vedrinne, JM ;
Dreyfuss, D ;
Coste, F ;
Mier, L ;
Faller, JP ;
Ruyer, O ;
Feissel, M ;
Engquist, A ;
Strom, J ;
Bonde, J ;
Desmonts, JM ;
Montravers, P ;
Lagoueyte, JF ;
Tenaillon, A ;
Lawkoune, JM ;
Boiteau, R ;
Cardinaud, JP ;
Benissan, G ;
Chastre, J ;
Gibert, C ;
Daoudal, P ;
Delacourt, M ;
Fouet, P ;
Hilpert, F ;
Smithies, M ;
Bihari, D ;
Perrotin, D ;
Dequin, PF .
CRITICAL CARE MEDICINE, 1998, 26 (12) :1963-1971